Splice variants of lysosome-associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells

Sunitinib, a tyrosine kinase inhibitor, is among the first-line treatments for metastatic or advanced stage renal cell carcinoma (RCC). However, patients with RCC develop resistance to sunitinib. We have previously demonstrated that lysosome-associated membrane protein 2 (LAMP-2), which has three sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Ryoma, Osaki, Mitsuhiko, Sasaki, Ryo, Ishikawa, Mizuho, Yumioka, Tetsuya, Yamaguchi, Noriya, Iwamoto, Hideto, Honda, Masashi, Kabuta, Tomohiro, Takenaka, Atsushi, Okada, Futoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551029/
https://www.ncbi.nlm.nih.gov/pubmed/32901843
http://dx.doi.org/10.3892/or.2020.7752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551029/
https://www.ncbi.nlm.nih.gov/pubmed/32901843
http://dx.doi.org/10.3892/or.2020.7752

Ejemplares similares